WHO's online stress tool put to the test in dutch workplaces

NCT ID NCT06979089

Recruiting now Symptom relief Sponsor: VU University of Amsterdam Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This study tests whether a free online program from the World Health Organization, called 'Doing What Matters in Times of Stress,' can help reduce anxiety and depression in employees of small and medium-sized Dutch companies. About 518 workers with elevated stress levels will either use the 5-week online program with phone support or continue with their usual care. The goal is to see if this simple, scalable approach can improve mental health and work-related outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Doing What Matters in Times of Stress (DWM) – an online stress management program based on acceptance and commitment therapy
What this could lead to: If it works, this could provide a simple, scalable online tool to improve mental health and reduce stress for employees in small and medium-sized businesses.
What could go wrong: This is a relatively small trial (518 people) testing a low-intensity program. The effects may be modest, and results may not apply to all workplaces or cultures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder cerebral palsy Depression depressive disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DEPRESSION PSYCHOLOGICAL DISTRESS

Contacts and locations

Locations

Vrije Universiteit Amsterdam
RECRUITING

Amsterdam, North Holland, 1081 HV, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.